Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry. - Wikidata - awgldk - TriplyDB

Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry.

Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry.

http://www.wikidata.org/entity/Q33842680

about

Proteomics investigations of HDL: challenges and promise Top-down proteomics in health and disease: challenges and opportunities Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure Mapping intact protein isoforms in discovery mode using top-down proteomics Quantitation and Identification of Thousands of Human Proteoforms below 30 kDa Quantitative proteomic analysis of histone modifications Applying label-free quantitation to top down proteomics.Qualitative and quantitative top-down mass spectral analysis of crustacean hyperglycemic hormones in response to feeding.Top Down proteomics: facts and perspectives.An algorithm for identifying multiply modified endogenous proteins using both full-scan and high-resolution tandem mass spectrometric data.Mapping O-glycosylation of apolipoprotein C-III in MALDI-FT-ICR protein profiles.Characterization and quantification of intact 26S proteasome proteins by real-time measurement of intrinsic fluorescence prior to top-down mass spectrometry.SAA: a link between cholesterol efflux capacity and inflammation?Top-down mass spectrometry: recent developments, applications and perspectives MASH Suite Pro: A Comprehensive Software Tool for Top-Down Proteomics.Targeting the glycoproteome A Method for Label-Free, Differential Top-Down Proteomics.The emergence of top-down proteomics in clinical research Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of serum amyloid A as a potential marker.Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithm Progress in Top-Down Proteomics and the Analysis of Proteoforms.Lights and shadows of proteomic technologies for the study of protein species including isoforms, splicing variants and protein post-translational modifications.The proteomic toolbox for studying cerebrospinal fluid.Analytical strategies for the global quantification of intact proteins.Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.Top-down Proteomics: Technology Advancements and Applications to Heart Diseases.Top-Down Mass Spectrometry: Proteomics to Proteoforms.Lipoprotein profiling methodology based on determination of apolipoprotein concentration.Novel "omics" approach for study of low-abundance, low-molecular-weight components of a complex biological tissue: regional differences between chorionic and basal plates of the human placenta.Three dimensional liquid chromatography coupling ion exchange chromatography/hydrophobic interaction chromatography/reverse phase chromatography for effective protein separation in top-down proteomics.Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain.Top-Down Targeted Proteomics Reveals Decrease in Myosin Regulatory Light-Chain Phosphorylation That Contributes to Sarcopenic Muscle Dysfunction.Effective protein separation by coupling hydrophobic interaction and reverse phase chromatography for top-down proteomics.Constructing comprehensive venom proteome reference maps for integrative venomics.Top-Down Proteomics: Ready for Prime Time?How many human proteoforms are there?Investigation of Ion Transmission Effects on Intact Protein Quantification in a Triple Quadrupole Mass Spectrometer.High-resolution mass spectrometry method for the detection, characterization and quantitation of pharmaceuticals in water.A Targeted, Differential Top-Down Proteomic Methodology for Comparison of ApoA-I Proteoforms in Individuals with High and Low HDL Efflux Capacity

P2860

Q27000995-36DE8E66-9529-4BD6-B1E4-866CFEBAC387 Q27002139-2EEC6496-1273-42B2-9B68-B050718C0A60 Q28243166-E48AE7B4-A1C6-4543-9343-3C42A843FF83 Q28251805-5A47FB2F-0BAD-41DB-B4C7-0CAE06135F16 Q29029578-C50C3051-600B-477F-886C-D2F0B6172787 Q30375585-C9267755-91A4-40F8-8608-06227630AAB2 Q33662342-2A1DF363-75E9-4BB8-B4FF-F3A07BF571AB Q33693100-7AC9D26C-BDA6-4FC0-9E13-8C3C7C1EF2CC Q33919966-C4FD3B5A-6C5B-4264-9F17-B79FDA30EA59 Q34077460-F5A3E699-C7C2-4A62-AD71-8C7AFF41EA0B Q34555445-6420C227-6EDB-4D3C-B119-CE0A607C2D7C Q34639141-A8EECE5F-79F1-4D1A-ADAB-8A424E8FD323 Q35886240-B6026771-CB7F-490D-B09C-BCA6B95DC174 Q36419886-5C53DECC-EA4C-4DDA-928B-CAE65339751C Q36539520-F8AE504B-F2A0-4A5C-9CF3-0ED5A31B2956 Q36554714-39E66C01-4E4E-4874-9DAF-62BB788DAAB8 Q36649014-3EFBE3DF-D5FC-4E7B-8809-B7CF6C4B3320 Q36998685-EE3150E9-D1C3-4FCB-933B-07D20AB28722 Q37456214-DA6D66E4-B969-42EC-8A56-13BBD080A267 Q37542168-7A2FB87D-5991-472E-A5B5-D77055BC57A2 Q37730532-33EF462B-7442-44A3-89AD-D55FB217733D Q37828113-21F3100A-3541-4155-891B-7A58D8438097 Q37998531-A88DE142-2C24-494E-8B13-B872D3ECFD92 Q38028382-03D163D9-3C06-4307-8B9F-A258F18251D6 Q38552059-27036F0A-3F49-49AD-9681-64F80C09B50D Q38905767-84A4AB67-9405-4E27-A8FC-CFBA7FD99A80 Q39038792-EC2A95DB-1D85-43D0-B257-680DB65B8DFD Q39127566-DAE86610-676B-4EC4-8754-0416440DB26D Q40561932-CAA6470C-9CF6-4A77-9426-4BE059D2E021 Q41082825-8E60DC15-A2D7-492C-92C8-CD30E708732B Q41529132-9DC99995-6540-44A3-83C4-AEB2F7DF9E62 Q42112173-89D0A077-0BA1-4C1B-85E8-844FB0B6C553 Q42841311-6729482C-1C67-484C-9A6F-70C8F85FE8EB Q46665082-5B03C16B-98F6-4D24-A0AA-368D4D63AFE0 Q48262177-E58FAB85-0429-4E23-89B3-28208B4D0B52 Q50001631-4AAF1719-8F24-4191-ADDF-FD6A9C74985C Q50969741-89E3B2F9-D630-4D10-BBCC-1CAD3E260D07 Q51487301-6F675B45-9312-42C2-8E64-09CD6EA74C87 Q56934006-F1606B06-C23A-49F4-9127-4426F29BF4FB

P2860

Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry.

http://www.wikidata.org/entity/Q33842680

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Quantitative analysis of intac ...... ifferential mass spectrometry.

@en

type

label

Quantitative analysis of intac ...... ifferential mass spectrometry.

@en

prefLabel

Quantitative analysis of intac ...... ifferential mass spectrometry.

@en

P1433

Q33842680-71F65187-8BE6-4BF4-83C6-214042237014

P1476

Q33842680-DB475BD6-D2ED-4E48-A358-3FE2B085A787

P2093

Q33842680-0E61C2E2-0B95-4655-8C79-A84B28DF7433

Q33842680-2A16944F-5D5B-40A9-A2CC-92D01A6D3958

Q33842680-6B3E3E6A-81E9-41DB-B53C-844974281E52

Q33842680-7FAD2919-FC5D-4D5A-88DD-6E893B8FAC36

Q33842680-9FCA72DB-D028-42F5-A001-EE99A9A41CEB

Q33842680-D77D8B8B-C171-407B-AF22-5CA5215DD6BD

P2860

Q33842680-06318EBE-8C35-4F98-8EAC-BD5E38CCB32B

Q33842680-06535523-B1AE-4D08-864B-A2F03362E750

Q33842680-08810E9F-7D6E-4DE2-9EC8-83CB06B7062C

Q33842680-093BEA8C-D010-4D6A-8309-5E6C89440842

Q33842680-1277BF19-0C18-4A0A-A112-E330CADFC33A

Q33842680-183985B1-944B-48A6-B756-A0A26BAD5823

Q33842680-2165BC9E-A170-47A8-B7A8-D7E2F5E83F67

Q33842680-2396E3AB-8A2B-461C-B11D-CD885C7B20EC

Q33842680-35431050-9D5F-45CC-B22F-6E3143223D45

Q33842680-3B8ED77A-335A-4EDF-924E-6CAA000BE0B8

P304

Q33842680-8C0485C5-F1EF-4AED-9F16-DAA79A5507B1

P31

Q33842680-9F69649F-683F-4450-9B2E-9E9A0AE28DA7

P356

Q33842680-09EA1164-63E5-436A-9CBF-CAE66934E5D0

P407

Q33842680-A241E7C2-C7E0-4E4E-ADFD-21D7B6089D64

P433

Q33842680-5B153312-4D68-416C-923D-9DB533C0CF12

P478

Q33842680-4F9755DC-CC54-4855-8050-1E3C949C983D

P577

Q33842680-201FCDF0-5F41-422E-A840-38450BEF5865

P5875

Q33842680-6C9F19EC-C59F-42AD-A0C6-9136857E3BE0

P698

Q33842680-6DA301FE-125E-477A-8FBF-AF83B8C2C57B

P932

Q33842680-9FEE739E-5E78-4F44-9FF9-B21021A02D78

P356

PNAS.0910776107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Quantitative analysis of intac ...... ifferential mass spectrometry.

@en

P2093

Andy Liaw

http://www.w3.org/2001/XMLSchema#string

Daniel S Spellman

http://www.w3.org/2001/XMLSchema#string

Helene L Cardasis

http://www.w3.org/2001/XMLSchema#string

Matthew T Mazur

http://www.w3.org/2001/XMLSchema#string

Nathan A Yates

http://www.w3.org/2001/XMLSchema#string

Ronald C Hendrickson

http://www.w3.org/2001/XMLSchema#string

P2860

ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia

Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry.

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

The utility of ETD mass spectrometry in proteomic analysis

Measurement of protein using bicinchoninic acid

Mass spectrometry of peptides and proteins

Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation

Analysis of intact proteins on a chromatographic time scale by electron transfer dissociation tandem mass spectrometry

Electron Capture Dissociation of Multiply Charged Protein Cations. A Nonergodic Process

A proteomic view of the Plasmodium falciparum life cycle

P304

7728-7733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0910776107

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43133966

http://www.w3.org/2001/XMLSchema#string

P698

20388904

http://www.w3.org/2001/XMLSchema#string

P932

2867874

http://www.w3.org/2001/XMLSchema#string